Navigation Links
5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
Date:12/23/2008

ed the latest technologies from the medical and biotech market aimed at improving and/or extending the human lifespan. The anti-aging industry is presently valued at US$ 96.89 Billion. With a compounded annual growth rate of 8.78%, the anti-aging industry is projected to reach US$ 115.5 Billion by 2010. [Global Industry Analysts, Inc., March 2008.

The A4M continues to advance a new paradigm of proactive interventions for dysfunctions, disorders, disabilities, and diseases led by advanced biomedical technologies that usher in unprecedented innovations in preventive medicine. As such, the A4M convenes the largest event of its kind in the arena of clinical advancements to prolong the healthy human lifespan: The Annual World Congress on Anti-Aging & Regenerative Biomedical Technologies convenes the world's most innovative physicians, scientists, health practitioners, industry leaders, and international government officials. During the organization's sixteen-year history, the A4M has embraced the vast potential benefits of some of the most promising aspects of scientific advancements in progressive preventive healthcare, many of which were highlighted at the Winter 2008 Session of the 16th Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies.

Observes Ronald Klatz, M.D., D.O., A4M President: "This scientific program drew a record-setting attendance of 5,000 physicians, scientists, health practitioners, industry leaders, and international government officials. For 70% of the conference's delegates, this was their first ever attendance of an anti-aging scientific conference. These numbers clearly demonstrate the continued and undeniable growth of the anti-aging medical movement." Adds Robert Goldman, M.D., Ph.D., D.O., FAASP: "With more than 70 countries represented, the Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies is the largest event of its kind in the ar
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Pittsburgh Area Resident Wins $15,000 In Online Sweepstakes
2. United Health Foundation Provides $45,000 for Scholarships to the American Indian College Fund for Arizona Healthcare Students
3. Drilling Engineers Donate $35,000 to Texas Childrens Hospital
4. Southern California Childrens Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less
5. Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000
6. Mother of Five Wins $5,000 in Minnesota Quit-Smoking Contest
7. Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series
8. 5,000 People Expected to March to End Homelessness in Los Angeles County
9. U.S. Reported 25,000 Cases of HPV-Related Cancers Annually
10. Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test
11. CollaborateMD Ranks in Top 100 Software Companies on 2008 Inc. 5,000
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
Breaking Medicine News(10 mins):Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3
Other Medicine News:Health News:Julie L. Novak Named Executive Director of Michigan State Medical Society 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 8Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 9Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 10Health News:National Health Care Coalition Commends New Congress' Focus on Fighting Chronic Disease in House Stimulus Package 2Health News:Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009 2Health News:Optelec and ShopLowVision.com Bring Life Back Into Focus at ATIA 2009 Orlando 2Health News:Optelec and ShopLowVision.com Bring Life Back Into Focus at ATIA 2009 Orlando 3Health News:Patients' Bath Basins Increase Risk for Hospital-Acquired Infections 2Health News:Patients' Bath Basins Increase Risk for Hospital-Acquired Infections 3
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Weight Loss Surgery Breaks Families Obesity Cycle 55987 1Weight Loss Surgery Breaks Families Obesity Cycle 55987 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 1Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 3Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 1Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 2Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 3
Other Medicine Technology:VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6